ChemicalBook >> CAS DataBase List >>Panobinostat

Panobinostat

CAS No.
404950-80-7
Chemical Name:
Panobinostat
Synonyms
CS-422;LBH-589;NVP-LBH589;Palcociclib;panobinosta;PANOBINOSTAT;2-Acrylamide;Palmer than he;Panobinostat D7;Panobinostat, >=98%
CBNumber:
CB61009161
Molecular Formula:
C21H23N3O2
Molecular Weight:
349.43
MDL Number:
MFCD09833242
MOL File:
404950-80-7.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-04-22 18:57:36
Product description Number Pack Size Price
Panobinostat P3137 10MG $43
Panobinostat ≥98% 13280 5mg $32
Panobinostat ≥98% 13280 10mg $61
Panobinostat ≥98% 13280 50mg $109
Panobinostat ≥98% 13280 5mg $29
More product size

Panobinostat Properties

Melting point 114-117C
Density 1.241±0.06 g/cm3(Predicted)
storage temp. -20°C Freezer, Under Inert Atmosphere
solubility Soluble in DMSO (up to 100 mg/ml) or in Ethanol (up to 5 mg/ml with warming).
pka 8.71±0.23(Predicted)
form solid
color Off-white
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month.
InChI InChI=1S/C21H23N3O2/c1-15-18(19-4-2-3-5-20(19)23-15)12-13-22-14-17-8-6-16(7-9-17)10-11-21(25)24-26/h2-11,22-23,26H,12-14H2,1H3,(H,24,25)/b11-10+
InChIKey FPOHNWQLNRZRFC-ZHACJKMWSA-N
SMILES C(NO)(=O)/C=C/C1=CC=C(CNCCC2C3=C(NC=2C)C=CC=C3)C=C1
NCI Dictionary of Cancer Terms LBH589; panobinostat
FDA UNII 9647FM7Y3Z
ATC code L01XH03
UNSPSC Code 12352200
NACRES NA.77

Pharmacokinetic data

Protein binding 90%
Excreted unchanged in urine <2.5%
Volume of distribution 1000 Litres
Biological half-life 37

SAFETY

Risk and Safety Statements

Symbol(GHS)  GHS hazard pictograms
GHS07
Signal word  Warning
Hazard statements  H315-H319
Precautionary statements  P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313
Risk Statements  22-36/37/38-20
Safety Statements  24/25
WGK Germany  WGK 3
HS Code  29339900
Storage Class 6.1C - Combustible acute toxic Cat.3
toxic compounds or compounds which causing chronic effects
Hazard Classifications Acute Tox. 3 Inhalation
Acute Tox. 3 Oral
Eye Dam. 1
Repr. 1B
Skin Irrit. 2
STOT RE 2 Inhalation
NFPA 704
0
4 0

Panobinostat price More Price(40)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
TCI Chemical P3137 Panobinostat 404950-80-7 10MG $43 2026-04-30 Buy
Cayman Chemical 13280 Panobinostat ≥98% 404950-80-7 5mg $32 2026-04-30 Buy
Cayman Chemical 13280 Panobinostat ≥98% 404950-80-7 10mg $61 2026-04-30 Buy
Cayman Chemical 13280 Panobinostat ≥98% 404950-80-7 50mg $109 2026-04-30 Buy
Cayman Chemical 13280 Panobinostat ≥98% 404950-80-7 5mg $29 2024-03-01 Buy
Product number Packaging Price Buy
P3137 10MG $43 Buy
13280 5mg $32 Buy
13280 10mg $61 Buy
13280 50mg $109 Buy
13280 5mg $29 Buy

Panobinostat Chemical Properties,Uses,Production

Description

Panobinostat is a potent inhibitor of all histone deacetylases (HDACs), with Ki values ranging from 0.6 to 31 nM for HDAC1-11. Through this action, it leads to acetylation of a range of cellular proteins, resulting in cell cycle arrest and apoptosis in cancer cells. It has potential applications in several different forms of cancer as well as in spinal muscular atrophy and HIV therapy.

Chemical Properties

Yellow Solid

Uses

The novel labelled histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells.

Uses

The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells.

Definition

ChEBI: A hydroxamic acid obtained by formal condensation of the carboxy group of (2E)-3-[4-({[2-(2-methylindol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enoic acid with the amino group of hydroxylamine. A histone deacetylase inhibitor used (as its la tate salt) in combination with bortezomib and dexamethasone for the treatment of multiple myeloma.

Clinical Use

Histone deacetylase (HDAC) inhibitor:
Treatment of relapsed and/or refractory multiple myeloma

Synthesis

Panobinostat Carboxylic Acid Methyl Ester Hydrochloride

441741-66-8

Panobinostat

404950-80-7

To a 250 mL four-necked flask was added (E)-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylic acid methyl ester hydrochloride (15 g, 0.039 mol) and methanol (75 mL) and cooled with stirring to -10°C to 15°C. Sodium hydroxide (4.68 g, 0.117 mol) was added rapidly to the methanol solution and stirred for 10 minutes after dropwise addition. Hydroxylamine solution (32.52 g, 50% aqueous solution, equivalent to 16.26 g, 0.234 mol of hydroxylamine hydrochloride) was then added dropwise and the reaction was stirred for 2 hrs keeping the temperature at -10°C to 15°C. The reaction mixture was slowly warmed up to -10°C to 15°C. The reaction mixture was then stirred for 10 min. The reaction mixture was slowly warmed to 0°C, held at 0-5°C for 30 minutes, then continued to warm to 20°C, held at 20-25°C for 1 hour. 38 mL of water was added dropwise, stirred for 10 minutes and filtered, and the filter cake was washed with 38 mL of water. The pH of the filtrate was adjusted to 10 with aqueous hydrochloric acid (~18.5 g of 2 mol/L aqueous solution). the crystals were stirred at 20-25°C and the pH was continued to 8-9 with hydrochloric acid (~15.5 g of 2 mol/L aqueous solution) and kept stirring at 20-25°C for 1 hour. The solution pH was further adjusted to 3-4 and the solid was filtered after stirring for 1 hour. The filter cake was rinsed with 50 mL of methanol-water mixture (v/v = 1:1) and dried to constant weight in a hot air oven at 50°C to afford the target product (E)-N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylamide 12.89 g in 94.6% yield.

target

HDAC (MOLT-4 cells)

Drug interactions

Potentially hazardous interactions with other drugs
Analgesics: avoid with dextromethorphan possibly increased risk of ventricular arrhythmias with methadone - avoid.
Anti-arrhythmics: increased risk of ventricular arrhythmias with amiodarone and possibly disopyramide - avoid.
Antibacterials: increased risk of ventricular arrhythmias with clarithromycin and moxifloxacin - avoid; avoid with rifampicin.
Antidepressants: avoid with St John’s wort.
Antiepileptics: avoid with carbamazepine, fosphenytoin, phenobarbital, phenytoin and primidone.
Antifungals: concentration increased by ketoconazole and possibly posaconazole and voriconazole - reduce panobinostat dose; concentration possibly increased by itraconazole - avoid.
Antimalarials: possibly increased risk of ventricular arrhythmias with chloroquine - avoid.
Antipsychotics: avoid with pimozide.
Antivirals: concentration possibly increased by ritonavir and saquinavir - reduce dose of panobinostat.
Beta-blockers: possibly increased risk of ventricular arrhythmias with sotalol - avoid.
Grapefruit juice: avoid concomitant use.
5HT3 antagonists: possibly increased risk of ventricular arrhythmias with granisetron and ondansetron - avoid with granisetron.

Metabolism

Panobinostat is extensively metabolised, and a large fraction of the dose is metabolised before reaching the systemic circulation by reduction, hydrolysis, oxidation and glucuronidation. Oxidative metabolism of panobinostat played a less prominent role, with approximately 40% of the dose eliminated by this pathway. Cytochrome P450 3A4 (CYP3A4) is the main oxidation enzyme, with potential minor involvement of CYP2D6 and 2C19.
Panobinostat represented 6-9% of the drug-related exposure in plasma. The parent substance is deemed to be responsible for the overall pharmacological activity of panobinostat.
After a single oral dose of [14C]-panobinostat in patients, 29-51% of administered radioactivity is excreted in the urine and 44-77% in the faeces. Unchanged panobinostat accounted for <2.5% of the dose in urine and <3.5% of the dose in faeces.

storage

Store at -20°C

References

[1] LING GENG. Histone deacetylase (HDAC) inhibitor LBH589 increases duration of gamma-H2AX foci and confines HDAC4 to the cytoplasm in irradiated non-small cell lung cancer.[J]. Cancer research, 2006, 66 23: 11298-11304. DOI:10.1158/0008-5472.can-06-0049
[2] PRINCE GEORGE. Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.[J]. Blood, 2005, 105 4: 1768-1776. DOI:10.1182/blood-2004-09-3413
[3] PATRICIA MAISO. The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.[J]. Cancer research, 2006, 66 11: 5781-5789. DOI:10.1158/0008-5472.can-05-4186

441741-66-8
404950-80-7
Synthesis of Panobinostat from Panobinostat Carboxylic Acid Methyl Ester Hydrochloride

Panobinostat Preparation Products And Raw materials

Global( 282)Suppliers
Supplier Tel Email Country ProdList Advantage
Hebei Yanxi Chemical Co., Ltd.
+8618531123677 faithe@yan-xi.com China 5853 58
Shaanxi Haibo Biotechnology Co., Ltd
+undefined18602966907 qinhe02@xaltbio.com China 997 58
Hebei Zhuanglai Chemical Trading Co.,Ltd
+8613343047651 admin@zlchemi.com China 3692 58
Capot Chemical Co.,Ltd.
+86-(0)57185586718; +8613336195806 sales@capot.com China 29640 60
Henan Tianfu Chemical Co.,Ltd.
+86-0371-55170693 +86-19937530512 info@tianfuchem.com China 21590 55
Nanjing ChemLin Chemical Industry Co., Ltd.
025-83697070 product@chemlin.com.cn CHINA 3009 60
ATK CHEMICAL COMPANY LIMITED
+undefined-21-51877795 ivan@atkchemical.com China 33024 60
career henan chemical co
+86-0371-86658258 +8613203830695 sales@coreychem.com China 29819 58
Biochempartner
0086-13720134139 candy@biochempartner.com CHINA 965 58
Shandong chuangyingchemical Co., Ltd.
18853181302 sale@chuangyingchem.com CHINA 5906 58

View Lastest Price from Panobinostat manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
Panobinostat pictures 2026-04-22 Panobinostat
404950-80-7
US $32.00-79.00 / mg 99.81% 10g TargetMol Chemicals Inc.
Panobinostat pictures 2025-06-20 Panobinostat
404950-80-7
US $10.00-1.00 / kg 1kg 0.99 20 tons Hebei Yanxi Chemical Co., Ltd.
Panobinostat pictures 2025-04-15 Panobinostat
404950-80-7
US $35.00 / kg 1kg 99% 5000kg/week Hebei Zhuanglai Chemical Trading Co.,Ltd
  • Panobinostat pictures
  • Panobinostat
    404950-80-7
  • US $32.00-79.00 / mg
  • 99.81%
  • TargetMol Chemicals Inc.
  • Panobinostat pictures
  • Panobinostat
    404950-80-7
  • US $10.00-1.00 / kg
  • 0.99
  • Hebei Yanxi Chemical Co., Ltd.
  • Panobinostat pictures
  • Panobinostat
    404950-80-7
  • US $35.00 / kg
  • 99%
  • Hebei Zhuanglai Chemical Trading Co.,Ltd

Panobinostat Spectrum

(E)-N-HYDROXY-3-(4-{[2-(2-METHYL-1H-INDOL-3-YL)-ETHYLAMINO]-METHYL}-PHENYL)-ACRYLAMIDE N-Hydroxy-3-[4-[2-(2-methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenamide LBH-589/Panobinostat LBH-589 PANOBINOSTAT 2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)-, (2E)- NVP-LBH589 Panobinostat (LBH589) (2E)-N-Hydroxy-3-[4-[[[2-(2-methyl-1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide N-Hydroxy-3-[4-[2-(2-methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenamide Panobinostat (LBH589) Panobinostat N-Hydroxy-3-[4-[2-(2-methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenamide panobinostat (HDAC inhibitor) Panobinostat (LBH589, NVP-LBH589) Palcociclib Panobinostat, >=98% LBH-589; LBH589; NVP-LBH589 CS-422 LBH 589 - NVP-LBH 589 | Panobinostat 3-[4-[2-(2-Methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenohydroxamic acid (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]prop-2-enamide Panobinostat USP/EP/BP 3-[4-[2-(2-Methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E... Panobinostat D7 3-[4-[2-(2-Methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenohydroxamic acid      N-Hydroxy-3-[4-[2-(2-methyl-1H-indol-3-yl)ethylaminomethyl]phenyl]-2(E)-propenamide Palmer than he LBH 589,Human immunodeficiency virus,Histone deacetylases,HIV,HDAC,LBH-589,Autophagy,inhibit,Panobinostat,Inhibitor,Apoptosis panobinosta 2-Acrylamide Papistatin impurity Panobinostat, 10 mM in DMSO 404950-80-7 C21H19D4N3O2 API Inhibitor Intracellular Signaling Aromatics Heterocycles Inhibitors Intermediates & Fine Chemicals Pharmaceuticals Isotope Labelled Compounds